ArticleDiscover oncology2025
Integrative analysis identifies FBXO5 as a critical mediator of CRPC progression and bone metastatic potential.
Rajnikant Raut et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it